Seeking Alpha

Optimer Pharmaceuticals, Inc. (OPTR): Q4 EPS of $0.02 may not be comparable to consensus of by...

Optimer Pharmaceuticals, Inc. (OPTR): Q4 EPS of $0.02 may not be comparable to consensus of by -$0.38. Gross product sales of $21.3M. Shares +11.5% premarket. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|